Search

everythinglearnresearchcommunity

for

Search:↓

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

The malignant pilomatricoma showed strong epithelial keratin expression, suggesting it may not calcify.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

AMH is a reliable marker for diagnosing PCOS.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Accurate diagnosis of rare pilomatrix carcinoma is crucial for effective treatment.

Matrical tumors share a common growth mechanism involving the Wnt pathway and consistent PHLDA1 expression.

AMH is a promising biomarker for diagnosing PCOS.

Higher estrone-to-estradiol ratios are linked to worse glucose metabolism and insulin resistance in women with PCOS.

High levels of Anti-Müllerian Hormone (AMH) in the blood can strongly predict Polycystic Ovarian Syndrome (PCOS) and related issues in women of reproductive age.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Overactive Wnt5a disrupts hair follicle orientation in mice.

Ovarian wedge resection helped regulate menstrual cycles but didn't significantly change hormone levels or hair growth in polycystic ovary syndrome.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Gut bacteria affect female reproductive health and may help diagnose and treat related diseases.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Hyperandrogenism and insulin resistance in PCOS-like rats can lead to pregnancy complications due to increased cell death in the uterus and placenta.

Cell division orientation varies by body site and is linked to epidermal thickness and cell density.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Female pattern hair loss and polycystic ovary syndrome are often linked.